These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16574702)

  • 21. Methamphetamine: history, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine.
    Vearrier D; Greenberg MI; Miller SN; Okaneku JT; Haggerty DA
    Dis Mon; 2012 Feb; 58(2):38-89. PubMed ID: 22251899
    [No Abstract]   [Full Text] [Related]  

  • 22. Ecstasy substance abuse.
    Nowicke CE
    Crit Care Nurse; 2004 Apr; 24(2):16. PubMed ID: 15098306
    [No Abstract]   [Full Text] [Related]  

  • 23. Eating attitudes, weight concerns and beliefs about drug effects in women who use ecstasy.
    Curran HV; Robjant K
    J Psychopharmacol; 2006 May; 20(3):425-31. PubMed ID: 16574717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. For alcohol alternatives, the science is not the hardest part.
    Room R
    J Psychopharmacol; 2006 May; 20(3):323-4, discussion 331. PubMed ID: 16574705
    [No Abstract]   [Full Text] [Related]  

  • 25. [Arthritis after ecstasy consumption].
    Duró JC; Monfort J; Farré M
    An Med Interna; 2001 Sep; 18(9):503-4. PubMed ID: 11715146
    [No Abstract]   [Full Text] [Related]  

  • 26. Understanding ecstasy.
    Outslay MG
    JAAPA; 2006 Jul; 19(7):42-7. PubMed ID: 16869151
    [No Abstract]   [Full Text] [Related]  

  • 27. An ecstatic case.
    Patel A
    Br Dent J; 2008 Mar; 204(6):282-3. PubMed ID: 18356857
    [No Abstract]   [Full Text] [Related]  

  • 28. [Has ecstasy neurotoxic effects in humans?].
    Rosenberg R
    Ugeskr Laeger; 1999 Dec; 161(50):6941. PubMed ID: 10643384
    [No Abstract]   [Full Text] [Related]  

  • 29. The impact of amphetamine-type stimulants on emergency services.
    Fulde GW; Forster SL
    Curr Opin Psychiatry; 2015 Jul; 28(4):275-9. PubMed ID: 26001917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ecstasy crackdown. Will the feds use a 1980s anti-crack law to destroy the rave movement?
    Cloud J
    Time; 2001 Apr; 157(14):62-4. PubMed ID: 11301990
    [No Abstract]   [Full Text] [Related]  

  • 31. The dangerous professor.
    Kupferschmidt K
    Science; 2014 Jan; 343(6170):478-81. PubMed ID: 24482461
    [No Abstract]   [Full Text] [Related]  

  • 32. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes.
    Reay JL; Hamilton C; Kennedy DO; Scholey AB
    J Psychopharmacol; 2006 May; 20(3):385-8. PubMed ID: 16574712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The politics of Ecstasy.
    Grob CS
    J Psychoactive Drugs; 2002; 34(2):143-4. PubMed ID: 12691204
    [No Abstract]   [Full Text] [Related]  

  • 34. The remote origins of a street drug.
    Aronson SM
    R I Med J (2013); 2014 Jul; 97(7):10. PubMed ID: 24983014
    [No Abstract]   [Full Text] [Related]  

  • 35. Methamphetamine and its impact on dental care.
    Klasser GD; Epstein J
    J Can Dent Assoc; 2005 Nov; 71(10):759-62. PubMed ID: 16324229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Adverse renal effects of legal and illicit drugs].
    Orth SR
    Ther Umsch; 2002 Mar; 59(3):122-30. PubMed ID: 11975400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute hyponatraemia.
    Watson ID; Serlin M; Moncur P; Tames F
    Postgrad Med J; 1997 Jul; 73(861):443-4. PubMed ID: 9338039
    [No Abstract]   [Full Text] [Related]  

  • 38. The meth menace: battling the fast-paced spread of methamphetamine may mean attacking it from several fronts.
    Boulard G
    State Legis; 2005 May; 31(5):14-8. PubMed ID: 15892208
    [No Abstract]   [Full Text] [Related]  

  • 39. Modelling the adverse effects associated with ecstasy use.
    Fisk JE; Murphy PN; Montgomery C; Hadjiefthyvoulou F
    Addiction; 2011 Apr; 106(4):798-805. PubMed ID: 21182557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to the comments by Cassel et al.
    Dumont GJ; Verkes RJ; Buitelaar JK; van Gerven JM
    Psychopharmacology (Berl); 2008 Oct; 200(3):451-2. PubMed ID: 18762917
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.